[HTML][HTML] Alzheimer's disease pathophysiology in the retina

BP Gaire, Y Koronyo, DT Fuchs, H Shi… - Progress in Retinal and …, 2024 - Elsevier
The retina is an emerging CNS target for potential noninvasive diagnosis and tracking of
Alzheimer's disease (AD). Studies have identified the pathological hallmarks of AD …

Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases

S Lista, A Vergallo, SJ Teipel, P Lemercier… - Ageing research …, 2023 - Elsevier
Acetylcholinesterase inhibitors (ChEI) are the global standard of care for the symptomatic
treatment of Alzheimer's disease (AD) and show significant positive effects in …

Retinal pathological features and proteome signatures of Alzheimer's disease

Y Koronyo, A Rentsendorj, N Mirzaei, GC Regis… - Acta …, 2023 - Springer
Alzheimer's disease (AD) pathologies were discovered in the accessible neurosensory
retina. However, their exact nature and topographical distribution, particularly in the early …

Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status

H Shi, N Mirzaei, Y Koronyo, MR Davis… - Acta …, 2024 - Springer
This study investigates various pathological tau isoforms in the retina of individuals with
early and advanced Alzheimer's disease (AD), exploring their connection with disease …

Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases

FJ Hart de Ruyter, MJAP Evers, THJ Morrema… - Acta …, 2024 - Springer
The retina is increasingly recognised as a potential source of biomarkers for
neurodegenerative diseases. Hallmark protein aggregates in the retinal neuronal tissue …

Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions

J Alber, F Bouwman, J den Haan… - Alzheimer's & …, 2024 - Wiley Online Library
There is emerging evidence that amyloid beta protein (Aβ) and tau‐related lesions in the
retina are associated with Alzheimer's disease (AD). Aβ and hyperphosphorylated (p)‐tau …

Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial

OM Dumitrascu, J Doustar, DT Fuchs… - Acta Neuropathologica …, 2024 - Springer
The relationship between amyloidosis and vasculature in cognitive impairment and
Alzheimer's disease (AD) pathogenesis is increasingly acknowledged. We conducted a …

Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid β-protein and phosphorylated tau

X Du, Y Koronyo, N Mirzaei, C Yang, DT Fuchs… - PNAS …, 2022 - academic.oup.com
Alzheimer's disease (AD) is a major risk for the aging population. The pathological hallmarks
of AD—an abnormal deposition of amyloid β-protein (Aβ) and phosphorylated tau (pTau) …

Artificial intelligence in ophthalmology: an insight into neurodegenerative disease

AD Patil, V Biousse, NJ Newman - Current Opinion in …, 2022 - journals.lww.com
In order to produce effective AI-DLS for the diagnosis and monitoring of neurodegenerative
disease, multicenter international collaboration is required to prospectively produce large …

[HTML][HTML] Color Fundus Photography and Deep Learning Applications in Alzheimer Disease

OM Dumitrascu, X Li, W Zhu, BK Woodruff… - Mayo Clinic …, 2024 - Elsevier
Objective To report the development and performance of 2 distinct deep learning models
trained exclusively on retinal color fundus photographs to classify Alzheimer disease (AD) …